← Open Payments lookup

JAE LEE: Open Payments

NPI 1073776985 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$969 in 32 payments from 14 companies in 2025. Trend: 2023 $755 · 2024 $620 · 2025 $969

Food & beverage: $969
CompanyPaymentsAmount
Madrigal Pharmaceuticals9$371
Takeda Pharmaceuticals U.S.A., Inc.5$125
Ipsen Biopharmaceuticals, Inc5$118
Gilead Sciences, Inc.1$103
Aimmune Therapeutics, Inc.1$35
Novo Nordisk Inc2$35
ABBVIE INC.2$31
Mallinckrodt Hospital Products Inc.1$29
Ardelyx, Inc.1$25
Exact Sciences Corporation1$23

Products named: REZDIFFRA, IQIRVO, Livdelzi, EOHILIA, ENTYVIO, VOWST, Wegovy, TERLIVAZ.

Industry payments across MD — which companies pay providers there.